Please login to the form below

Not currently logged in
Email:
Password:

Actelion appoints former GSK CEO as chair

Dr Jean-Pierre Garnier, former CEO at GlaxoSmithKline, has been appointed chairman of Swiss biopharmaceutical company Actelion

Dr Jean-Pierre Garnier - ActelionDr Jean-Pierre Garnier, former CEO at GlaxoSmithKline (GSK), has been appointed chairman of Swiss biopharmaceutical company Actelion.

He will take over from Robert Cawthorn who will remain in the role until the company's annual general meeting in 2012.

Garnier was first appointed to Actelion's board of directors at the company's annual general meeting on May 5, 2011.

His previous positions include the CEO of GSK following the merger of SmithKline Beecham and Glaxo Wellcome in 2001. He remained at GSK until 2008 when he became CEO of French pharmaceutical and cosmetics company Pierre Fabre Labs.

Prior positions at SmithKline Beecham include president of the company's pharmaceutical business in North America, as well as chairman of its pharmaceuticals division and chief operating officer.

Jean-Paul Clozel, co-founder and CEO of Actelion, described Garnier as "one of the world's most renowned pharma managers" following the announcement.

He said: "He is the right person to lead Actelion into the next stage of the company's development."

28th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics